Show items per page
Elements: 7
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers Ashton, N J; Leuzy, A; Karikari, T K; Mattsson-Carlgren, N; ... Hansson, O 2021
add to browser selection
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework Leuzy, A; Ashton, N J; Mattsson-Carlgren, N; Dodich, Alessandra; ... Hansson, O 2021
add to browser selection
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes Klingenberg, Roland; Aghlmandi, Soheila; Räber, Lorenz; Akhmedov, Alexander; ... Matter, Christian M 2021
add to browser selection
Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia Mairesse, Jérôme; Zinni, Manuela; Pansiot, Julien; Hassan-Abdi, Rahma; ... Baud, Olivier 2019
add to browser selection
Neurodegenerative cerebrospinal fluid biomarkers tau and amyloid beta predict functional, quality of life, and neuropsychological outcomes after aneurysmal subarachnoid hemorrhage Joswig, Holger; Korte, Wolfgang; Früh, Severin; Epprecht, Lorenz; ... Stienen, Martin 2018
add to browser selection
Amyloid-β plaque deposition measured using propagation-based X-ray phase contrast CT imaging Astolfo, Alberto; Lathuiliere, Aurélien; Laversenne, Vanessa; Schneider, Bernard; Stampanoni, Marco 2016
add to browser selection
Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism Raposinho, PD; Pierroz, DD; Broqua, Pierre; White, R B; ... Aubert, Michel 2001